Skip to main content
. 2015 Jul 7;2:10.3402/ecrj.v2.27768. doi: 10.3402/ecrj.v2.27768

Table 3.

Baseline anti-asthma treatment of the 190 patients with asthma-like symptoms enrolled in the present study

Non-specific respiratory symptoms Asthma Total p
68 (36%) 122 (64%) 190 (100%)
% ICS treateda 22 38 33 0.058
% ICS/LABA treateda 20 35 30 0.057
% β2 treatedb 66 86 79 0.01
a

Patients with a history of inhaled steroid (ICS) with and without long-acting β2-agonist (LABA)

b

Patients with a history of bronchodilator treatment.